Matthew Whalen
Net worth: - $ as of 2026-07-30
Net worth: - $ as of 2026-07-30
Mr. Matthew P.
Whalen, CPA, is an Independent Director at MIRA Pharmaceuticals, Inc., an Independent Director at Telomir Pharmaceuticals, Inc. and a Chief Financial Officer at Power Digital Marketing, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. and Telomir Pharmaceuticals, Inc. Mr. Whalen was previously employed as a Chief Financial Officer by MRC Smart Technology Solutions, Inc. He received his undergraduate degree from the University of San Diego.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-20 | 0 ( -.--% ) | - $ | 2026-07-30 | |
| 2026-07-20 | 0 ( -.--% ) | - $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 2024-08-11 |
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 2024-11-17 |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Director of Finance/CFO | - |
| Companies | Position | End |
|---|---|---|
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Director of Finance/CFO | 2021-04-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Commercial Services |
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Commercial Services |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Select your edition
All financial news and data tailored to specific country editions